List view / Grid view
The global market for growth hormone deficiency (GHD) treatment will rise in value from $1.26 billion in 2014 to reach approximately $1.88 billion by 2024, representing a moderate Compound Annual Growth Rate (CAGR) of 4.08%, according to research and consulting firm GlobalData.
18 August 2015 | By Victoria White
An international study of people with a family history of cancer has shown that a regular dose of aspirin reduces the long-term risk of the disease...
18 August 2015 | By Victoria White
Interim results from the B-YOND study support the long-term safety and efficacy of Alprolix in people with severe haemophilia B treated for up to two years...
18 August 2015 | By Victoria White
NICE, the UK health watchdog, has published guidance to help doctors, nurses and pharmacists promote and monitor the sensible use of antibiotics...
17 August 2015 | By Victoria White
The EC has granted Marketing Authorisation for dinutuximab for the treatment of high-risk neuroblastoma in patients aged 12 months to 17 years...
17 August 2015 | By Victoria White
An epidemiological week has now passed with no new Ebola cases in Sierra Leone for the first time since the beginning of the outbreak...
17 August 2015 | By Victoria White
New data show Spiolto Respimat provides consistent, clinically meaningful improvements in quality of life versus placebo in patients COPD...
17 August 2015 | By Victoria White
Ferring Pharmaceuticals has started patient enrollment in a Phase 2b/3 clinical trial of selepressin for the treatment of septic shock...
17 August 2015 | By Victoria White
The ISS has recommended that Mylan shareholders vote "against" the unsolicited offer to acquire all of the outstanding shares of Perrigo...
17 August 2015 | By Victoria White
The number of people living with diabetes in the UK has soared by nearly 60% in a decade, according to a new analysis by Diabetes UK...
17 August 2015 | By Victoria White
In Roche’s large pivotal Phase II study, BIRCH, atezolizumab met its primary endpoint and shrank tumours in people with locally advanced or metastatic NSCLC...
13 August 2015 | By Katie Sadler, Digital Content Producer, European Pharmaceutical Review
Roche has announced the acquisition of GeneWEAVE BioSciences Inc. to strengthen its offering in the field of microbiology diagnostics.
13 August 2015 | By CPhI China
CPhI – a division of UBM EMEA – alongside UBM Sinexpo, announces the findings of the Pharma Insights China 2015 report.
12 August 2015 | By Sartorius
Redesigned Sartobind® membrane adsorber capsules offer higher binding capacities, reduced void volumes, less buffer consumption and lower operational costs...
12 August 2015 | By Katie Sadler, Digital Content Producer, European Pharmaceutical Review
Roche have announced positive results from the Phase II M13-982 study of venetoclax, an investigational medicine developed for hard-to-treat chronic lymphocytic leukaemia.
